Additional Information for Etretinate Capsules
Etretinate Capsules are a type of medication that belongs to the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Etretinate is a retinoid medication that is used to treat severe psoriasis, a chronic skin condition characterized by red, itchy, and scaly patches on the skin. It works by slowing down the growth of skin cells and reducing inflammation.
Etretinate Capsules are taken orally and are available in different strengths. They are typically prescribed by a healthcare professional and should be taken exactly as directed. It is important to follow the prescribed dosage and duration of treatment to achieve the best results.
Like any medication, Etretinate Capsules may have potential side effects. Some common side effects include dry skin, dry eyes, dry mouth, joint pain, and hair loss. It is important to discuss any concerns or side effects with a healthcare professional.
Etretinate Capsules should not be used by pregnant women or women planning to become pregnant, as it can cause severe birth defects. It is also important to avoid alcohol consumption while taking Etretinate, as it can increase the risk of liver damage.
Overall, Etretinate Capsules are a medication used to treat severe psoriasis and should be used under the guidance of a healthcare professional.
Related Item Names for INC 40212 Etretinate Capsules
NATO Stock Numbers with Item Name 40212 Etretinate Capsules Page 1 of 1
- 961144
- RNCC: 5 | RNVC: 2 | DAC: 9
- TIGASON
- RNCC: 3 | RNVC: 1 | DAC: 4